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1 Introduction 
cDNA sequence of the 38-kDa fragment of H carrying the binding site for C3b 1351 
Human complement factor H: isolation of cDNA clones 
and partial cDNA sequence of the 38-kDa tryptic 
fragment containing the binding site for C3b* 
We isolated cDNA clones coding for the functionally important tryptic N-terminal38- 
kDa fragment of human complement control protein factor H using polyclonal and 
monoclonal antibodies to screen a human liver cDNA library cloned in a bacterial 
expression vector, PEX-1. By testing the reactivity of antibodies specific for the 
recombinant proteins produced by individual clones with proteolytic fragments of 
serum H the exact position of these cDNA clones within H was mapped. One clone, 
H-19, coding for the 38-kDa fragment of H was sequenced and found to code for 289 
amino acids derived from the 38-kDa N-terminal fragment as well as for the first 108 
amino acids belonging to the complementary 142-kDa tryptic fragment. The derived 
protein sequence could be arranged in 6 highly homologous repeats of about 60 amino 
acids each, the homology between the repeats being determined by the characteristic 
position of cysteine, proline, glycine, tyrosine and tryptophane residues. The region 
coding for the epitope recognized by one of our monoclonal antibodies was localized 
by subcloning restriction fragments of H-19 into the expression plasmid and testing 
for the expression of this epitope. 
Human factor H is a plasma glycoprotein of approximate mol. 
mass of 150-kDa which regulates the C3 and C5 convertases of 
the alternative pathway of complement activation. It acceler- 
ates the decay of the alternative pathway C3 convertase 
(C3bBb) [l-31 and also acts as a cofactor for the enzyme fac- 
tor I which cleaves the a chain of C3b, thus converting C3b to 
the hemolytically inactive iC3b [4]. In this mode of action it is 
similar to CCbinding protein, C4-BP, which mediates the 
cleavage of C4b by I [5] and to complement receptor type one 
(CR1 or C3b receptor), which as an integral membrane 
molecule also mediates the cleavage of C3b by factor I [6, 71. 
As in the case of the three complement components needed to 
form the C3 convertases of the classical and alternative path- 
way, i.e. factors C4, C2 and B (for review see [S]), there is also 
a polymorphism of the three control proteins factor H, C4-BP 
and CR1 [9-111. Individual alleles of H, C4-BP and CR1 are 
linked [12] and recent work indicates that this group of genes is 
localized on chromosome 1 in humans [13]. Apart from being 
a serum protein synthesized by hepatocytes, factor H is also 
found in platelets [14] and monocytes [15] and small amounts 
of H can be found to be associated with the plasma membrane 
of B lymphocytes [16]. Here it contributes to the binding of 
C3b-coated immune complexes to these cells in addition to 
CR1 [16]. Furthermore, H has been shown to bind to B lym- 
phocytes and monocytes by means of a receptor [17, 181, to 
stimulate the respiratory burst of and to induce the release of 
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factor I from human monocytes [19, 201, as well as to induce 
proliferation in murine B cells [21]. 
Using monoclonal antibodies to H and by means of limited 
proteolytic digestion we have recently been able to localize 
functionally important domains on the molecule and to devise 
a model of the structure of factor H [16,22,23]. According to 
these results, factor H consists of subunits of at least 15-kDa 
mol. mass that are linked together by disulfide bridges and 
which can be separated from each other by cleavage with ficin. 
The binding site for C3b and the domain responsible for the 
cofactor function for factor I are localized on a N-terminal38- 
kDa tryptic fragment of H which also carries the epitopes for 
6 monoclonal antibodies. The function of the complementary 
142-kDa tryptic fragment is unclear at present. 
In this study we set out to isolate cDNA clones coding for this 
functionally important 38-kDa fragment of H. 
2 Materials and methods 
2.1 Factor H 
Factor H was purified from fresh human plasma as previously 
described [22]. Without reduction the purified protein showed 
one band of 150-kDa on silver-stained sodium dodecyl sulfate- 
(SDS)-polyacrylamide gels. After treatment with 1 % 2-mer- 
captoethanol the molecular mass shifted to 160-kDa and a 
fragment of 38-kDa became visible (see Fig. 2, Sect. 3.2), 
indicating that a small proportion of the factor H preparation 
used in this study had been exposed to proteolysis during the 
purification. Treatment of factor H with trypsin (enzyme: sub- 
strate ratio 1 : 100 w/w in phosphate-buffered saline, PBS), 
pepsin (e : s 1 : 1000 in 0.1 M N sodium citrate, pH 2) and elas- 
tase (e : s 1 : 10 in PBS, pH 8.5), was performed for 5 min and 
60 min at 37°C and the reaction then stopped with 2 mM DFP 
(trypsin, elastase) or adjusting the pH to 7.5 (pepsin) and 
freezing at - 20°C. Five-min and 60-min fragments obtained 
with each enzyme were then pooled and used on Western 
blots. 
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2.2 Antibodies 2.6 Preparation and sequence analysis of cloned cDNA 
A polyclonal goat antibody to H was affinity purified on 
Sepharose-bound H by standard methods. Monoclonal anti- 
bodies to H, MAH 1-3, were described previously [16] and 
MAH-4 was obtained in a similar fashion. OX-23 and OX-24, 
also directed at H, were a kind gift from Dr. R. Sim, Oxford, 
GB. All monoclonal antibodies bind to the 38-kDa N-terminal 
fragment of H and MAH-1, MAH-2, MAH-4 inhibit the bind- 
ing of H to C3b as well as the cofactor function of H for I [16, 
22, 231. 
Small-scale plasmid preparations were performed by the 
alkaline-SDS method [26]. Large-scale plasmid preparations 
were further purified by isopycnic centrifugation on CsCl[27]. 
The 1.5-kb insert of clone H-19 was digested with Sau 3A, Sma 
and these fragments were subcloned into M13 for sequencing 
by the Sanger dideoxy chain termination method [28]. In the 
regions indicated in Fig. 5 (see Sect. 3.4) the sequence was 
confirmed by additional sequencing by the Maxam-Gilbert 
method [29]. 
2.3 Screening of a human liver cDNA library 3 Results 
A human liver cDNA library cloned in the expression plasmid 
PEX-1 as previously described [24] was screened using an 
immunoperoxydase method [24] to detect colonies that 
reacted with a polyclonal antibody to H. Positive colonies 
were recloned and screened with an affinity purified antibody 
and with monoclonal antibodies to H. 
2.4 SDS-polyacrylamide gel electrophoresis (PAGE) and 
Western blot for fusion proteins 
Two hundred p1 of an overnight bulk culture of a given clone 
were added to 20 ml of LB-broth and incubated at 30°C with 
vigorous shaking to an optical density (600 nm) of 0.2-0.3. 
The incubation temperature was then quickly raised to 42 "C 
and the culture incubated for a further 90 min. The bacteria 
were pelleted by centrifugation and lysed in 2 ml of 50 mM 
Tris-HC1 pH, 6.8 containing 5% SDS, 2% 2-mercaptoethanol, 
10% glycerol and bromophenol blue. After boiling for 5 min, 
20 pl of this extract was electrophoresed on a 7.5-15% SDS- 
polyacrylamide gradient gel. Transfer to nitrocellulose (West- 
ern blot) and staining with polyclonal or monoclonal anti- 
bodies, peroxidase-conjugated second antibody and 
diaminobenzidine as substrate (0.5 mg/ml in Tris, 50 mM 
pH 7.4, 0.006% H,O,) was performed by standard methods 
1251. 
2.5 Affinity purification of antibodies on fusion proteins 
Ten to 20 lanes of a 7.5-15% polyacrylamide gradient gel 
were loaded with SDS extracts from a bacterial culture that 
had been induced to produce recombinant proteins as 
described above. After electrophoresis and Western blotting 
the nitrocellulose filter was blocked in washing buffer (PBS 
containing 0.1% Triton X-100 and 0.5% gelatine) and a small 
strip was cut off from one side. This strip was stained with 
polyclonal antibody to H, peroxidase-conjugated second anti- 
body and substrate as above to localize the position of recom- 
binant proteins containing a part of H. 
After aligning the stained strip with the rest of the nitrocellu- 
lose filter areas of the filter containing these recombinant pro- 
teins were cut out and incubated with 1 ml of goat anti-H 
antibody in washing buffer for 1 h at room temperature. After 
three washes in washing buffer bound antibody was eluted 
with 1 ml of 0.1 M glycine, pH 2.2 (5 min at 4"C), and the 
eluted antibody was neutralized with 1.5 M Tris, pH 8.8 and 
diluted with an equal volume of washing buffer. 
3.1 Isolation and characterization of cDNA clones for factor H 
from a human cDNA library cloned into an expression 
vector 
Approximately 50 000 colonies of a previously reported human 
cDNA library [24] cloned into PEX-1, a bacterial high-effi- 
ciency expression vector, were screened with a polyclonal anti- 
body to H using an immunoperoxidase method to detect posi- 
tive clones. Out of 8 positive clones reacting with an affinity- 
purified polyclonal antibody to H, two designated H-2 and H- 
19 also reacted with two monoclonal antibodies to H,  MAH-4 
and OX-24. These two clones produced an identical fusion 
protein of approx. 160-kDa (Fig. 1) consisting of a 117-kDa 
cro-P-galactosidase part derived from PEX-1 [24] and an 
approx. 40-kDa fragment of factor H. In addition, H-specific 
bands of about 40 and 50 kDa were observed. Since both H-2 
and H-19 also contained an identical insert of 1.5 kb it was 
assumed that they were identical and analysis was continued 
with H-19. Another clone, H-3, containing an insert of 700 bp, 
reacted with monoclonal antibody MAH-1. 
Three additional distinct clones reacting only with the affinity- 
purified antibody to H and containing inserts of 1.4 kb, 
0.95 kb and 2.2 kb were identified and designated H-40, H-46 
and H-49, respectively. They have been described in detail 
elsewhere [30]. 
Figure 1. Western blot of recombin- 
ant proteins produced by H-2, H-19 
and PEX-1. Twenty p1 of a lysate of 
bacteria containing plasmids H-2 
(lane l), H-19 (lane 2) or PEX-1 
(lane 3) that had been induced to 
produce recombinant proteins as de- 
scribed in Sect. 2.4 was electrophor- 
esed on a SDS-polyacrylamide gel 
and blotted to nitrocellulose. The 
blot was then stained with mono- 
clonal antibodies MAH-4 and OX- 
24, peroxidase-conjugated second 
antibody and diaminobenzidine. 
Numbers on the right denote appa- 
rent mol. mass in kDa of marker 
proteins. 
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3.2 Mapping of the position of cDNA clones within H 
Since the recombinant proteins of H-19 reacted with the two 
monoclonal antibodies MAH-4 and OX-24 known to bind to 
the 38-kDa tryptic N-terminal fragment of H [23], we con- 
cluded that H-19 codes for at least a part of this fragment. To 
map the position of H-19 more precisely with respect to the 
known proteolytic fragments of H, we affinity purified a poly- 
clonal antibody to H on the H-specific proteins produced by 
H-19 and then tested to which of several proteolytic fragments 
of H this “clone-specific” antibody would bind. On Western 
blots of tryptic H fragments (partial digest, Fig. 2) “anti-H-19” 
bound to the 38-kDa fragment but not to the 142-kDa frag- 
ment or the 52-kDa and 95-kDa bands derived from the latter 
[22] indicating that H-19 should code for the 38-kDa fragment 
without overlapping with immunogenic regions within the 142- 
kDa fragment. 
Since “anti-H-19” also reacted with pepsin fragments of 38- 
kDa, 42-kDa, 50-kDa, 55-kDa and 65-kDa as well as with 
1 2 3 4  5 6 7 8  
Figure 2. Mapping of the position of clone H-19 with respect to pro- 
teolytic fragments of H. A polyclonal antibody to H (lanes 1-4) and 
the same antibody previously affinity purified on the recombinant 
proteins produced by H-19 (Fig. 1) (lanes 5-8) were used to stain 
Western blots of purified H (lanes 1, 5 )  as well as peptic (lanes 2 ,  6), 
tryptic (lanes 3, 7) and elastase (lanes 4, 8) fragments from partial 
digests of H separated by SDS-PAGE. Numbers between the two 
blots denote apparent molecular mass in kDa. 
elastase fragments of 38-kDa and 28-kDa, these fragments 
(from a partial digest) must be contained in or extend into the 
tryptic 38-kDa fragment of H. 
Similar experiments performed with H-46 and H-49 revealed 
that both clones code for regions within the 142-kDa tryptic 
fragment of H (not shown). Polyclonal antibodies affinity 
purified on H-3 and H-40 did not stain any of the H fragments 
(not shown) and could therefore not be mapped precisely. 
3.3 Sequence analysis of H-19 
A nucleotide sequence of 1429 base pairs was derived from H- 
19. The first 915 nucleotides translated into a protein sequence 
of 305 amino acids which could be arranged in 5 highly 
homologous repeats of about 60 amino acids each (Fig. 3). 
Likewise nucleotides 941 to 1193, if read in a different reading 
frame, also coded for a protein sequence with a similar inter- 
nal homology pattern (Figs. 3 and 4). Therefore, H-19 must 
contain a shift in reading frame somewhere between nuc- 
leotides 915 and 941. With the help of a recently published 
partial sequence of H covering this region [31] the change in 
reading frame could be attributed to an additional A at posi- 
tion 930 present in H-19. As outlined in the discussion this is 
probably a cloning artefact and the complete protein sequence 
coded for by H-19 therefore comprised 397 amino acids form- 
ing 6 112 highly homologous repeats of about 60 amino acids 
each with the positions of cysteine, tryptophane, proline, gly- 
cine and tyrosine residues highly conserved (Fig. 3). The pro- 
tein sequence contained one potential glycosylation site at 
asparagine residue 165 (Asn-Gly-Ser). The coding sequence 
of H-19 stopped at nucleotide 1193 and was followed by a 
232 bp 3‘ untranslated region containing a putative poly- 
adenylation signal (ATTAAA) located 15 bp upstream of a 
poly A tail. 
3.4 Mapping of the position of the OX-24 epitope 
To identify the region containing the epitopes recognized by 
MAH-4 and OX-24 the insert of clone H-19 was digested with 
Sau 3A. A pool of these fragments was cloned into the Bam- 
HI site of PEX-1/2/3. After transformation of E. coli (strain 
POP2436) colonies were screened for the expression of MAH- 
4/0X-24 epitopes. Positive clones were chosen and their 
inserts analyzed by restriction enzyme digestion. Whereas the 
MAH-4 epitope seemed to be destroyed by subcloning we 
obtained one clone, H-19-6, reacting with OX-24, which was 
shown to contain an internal Sma site. This places the domain 
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Figure 3. Assignment of the protein sequence 
derived from H-19 to 6 1/2 homology subunits of 
about 60 amino acids each. Identical amino 
acids present in several of the 6 homologous re- 
gions are boxed. Gaps denoted by “-” have 
been introduced to maximize homology and to 
allow space for the regions with short inserted 
sequences. The potential glycosylation site (re- 
sidue 165; Asn-Gly-Ser) and the tryptic cleav- 
age site (residues 2891290; Arg-Arg) marking 
the end of the 38-kDa tryptic N-terminal frag- 
ment are underlined. 
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Figure 4. Nucleotide sequence derived from H-19. Numbers on the right denote nucleotides (top) and amino acid residues (bottom). The arrow 
denotes the additional A residue causing the observed shift in reading frame. The putative A'ITAAA polyadenylation signal is boxed. 
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Figure 5. Insert of clone H-19: restriction map, position of the derived 
protein sequence and of the area containing the OX-24 epitope as well 
as strategy used for sequencing and site of the observed shift in reading 
frame. B: Bam H1, Bg: BglII, Sa: Sau 3A, H: Hinf 1, S: Sma. The 
shaded areas denote the position of the protein sequence derived from 
H-19. The gap interrupting the two shaded areas represents the site of 
the observed shift in reading frame. Solid arrows represent the length 
of subclones and for sequencing by the sanger dideoxy chain termina- 
tion method [28] and the direction of sequencing. The dashed arrow 
represents the piece of H-19 sequenced by the Maxam-Gilbert method 
[29]. The part of the sequence coding for the OX-24 epitope is desig- 
nated by a bar (w). 
coding for OX-24 between residues 167 and 290 of H-19 (i.e. 
between the Sau 3A site at nucleotide 501 and the carboxyter- 
minus of the 38-kDa fragment, Fig. 5). 
4 Discussion 
The 38-kDa N-terminal tryptic fragment of H carries the bind- 
ing site for C3b, and in purified form is capable of acting as a 
cofactor in the fluid-phase cleavage of H by I [22]. The use of 
monoclonal antibodies binding to this fragment [16, 231 for 
screening an expression library enabled us to identify two 
probably identical clones, H-2 and H-19, coding for this region 
of H. Apart from isolating cDNA clones the expression vector 
also permitted an exact mapping of the cDNA clones with 
respect to the known proteolytic fragments of H prior to se- 
quence analysis by using polyclonal antibodies affinity purified 
on the recombinant proteins. The fact that two monoclonal 
antibodies, MAH-4 and OX-24, reacting with distinct epitopes 
on H [32] both bind to H-19 makes it very likely that this 
cDNA clone codes for H and not for a protein merely related 
to H by a single epitope. 
H-19 was found to contain the coding sequence for 397 amino 
acids of human H. There was a trypsin cleavage site at amino 
acid residues 289/290 (Arg-Arg), which must represent the car- 
boxyterminus of the 38-kDa tryptic fragment of H since the 
sequence Arg-Pro-Tyr-Phe-Pro on the right of this cleavage 
site is identical to that derived from the aminoterminus of the 
142-kDa tryptic fragment of H (V. Malhotra and R. Sim, per- 
sonal communication). Therefore, H-19 codes for the first 
108 amino acids of the 142-kDa fragment in addition to the 
289 amino acids derived from the 38-kDa fragment. This was 
unexpected since antibodies affinity purified on the fusion pro- 
tein produced by H-19 only reacted with the 38-kDa fragment 
of H (Fig. 2). However, as shown in Fig. 4, the cDNA se- 
quence derived from H-19 contained an additional A residue 
at position 930 which was not observed in a recently published 
cDNA clone covering this particular part of H [31] and which 
caused a shift in reading frame. As a consequence only the first 
20 amino acids of the 142-kDa fragment were expressed in the 
correct reading frame and this was probably not enough to 
absorb sufficient antibody that would react with the 142-kDa 
fragment. This also underlines that the additional A residue at 
position 930 was not a sequencing artefact but really present in 
H-19, probably due to an error that occurred during reverse 
transcription. The previously reported amino-terminal se- 
quence of the 38-kDa fragment of H was not covered by the 
H-19 sequence. By analogy with the recently reported se- 
quence for murine H [33] one would expect the aminoterminus 
of H to be about 30 amino acids from the beginning of the se- 
quence derived from H19. Therefore, H-19 covers most of the 
38-kDa amino-terminal fragment of H. 
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It was therefore surprising to find a poly A tail at the 3' end of 
H-19. However, exactly the same 3' untranslated region as 
well as a poly A tail were found in a recently published shorter 
cDNA clone for H [31]. A clone coding for the aminoterminus 
of the C5 a chain also contained an unexpected poly A tail 
[34]. Since all these as well as our clone were derived from 
acute phase liver cDNA libraries it is possible that this finding 
reflects the presence of alternative H specific mRNAs under 
acute phase conditions. 
As shown in Fig. 3 the partial H sequence reported here 
revealed a marked internal homology and could be arranged in 
6 112 homologous repeats of about 60 amino acids each with 
the positions of cysteine, glycine, proline, tryptophane and 
tyrosine residues highly conserved. Apart from human H,  
similar repeats have been found in murine H [33] as well as in 
C4BP [35] and CRl [13], both cofactors for I in the cleavage of 
C4b and/or C3b [4, 5, 71 and probably encoded on the same 
chromosome as H [ 121, It is therefore possible that these three 
cofactors for I evolved from a common ancestor gene by gene 
duplication. In addition, similar subunits have been observed 
in the N-terminal Ba fragment of complement factor B, in C2, 
in P2-glycoprotein I and interleukin 2 receptor [36, 371. 
Subcloning restriction fragments of H-19 in PEX 1/2/3 allowed 
the localization of the OX24 epitope between amino acid 
residues 167 and 290 of H19. The fact that the MAH-4 epitope 
was destroyed by subcloning further underlines that OX-24 
and MAH-4 recognize distinct epitopes as had been predicted 
on the basis of inhibition studies. The availability of a cDNA 
clone for human H will allow the study of the molecular organ- 
isation of the factor H gene on chromosome 1 and its relation- 
ship to the genes for CR1 and C4BP. 
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